Rising prevalence of atrial fibrillation, especially among the geriatric population to drive growth
of the atrial fibrillation market
AF increases the life expectancy of a patient, thus the demand for atrial fibrillation is increasing
for treatment of the geriatric population. Growing adoption of catheter ablation and
advancements in technology are expected to fuel growth of the market for atrial fibrillation.
However, lack of skilled professionals and alternative options over AF healing devices are
projected to hamper growth of the atrial fibrillation market. According to the National Center
for Biotechnology Information (NCBI), the prevalence of AF is estimated to double in a span of
two decades (2010–2030). Several government initiatives are working towards making AF more
accessible to the general populace. For instance, favorable regulatory steps such as ‘National
Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS)’
undertaken by the Government of India, which aims to prevent and control premature mortality
and morbidity from cardiovascular diseases, stroke, and diabetes mellitus. This I turn, is
expected to propel growth of the market during the forecast period.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/205
North America holds a dominant position in the market, accounting for the largest market
share. The dominance of the market in the region is attributed to high presence of advanced
healthcare facilities and higher adoption of technologically advanced devices and treatment
measures such as AF in countries such as U.S. and Canada, in the region. The market in Asia
Pacific is projected to witness substantial growth in the near future, owing to the growing
population in the region and rapidly aging population, who are highly vulnerable to heart
diseases. Also, demand for atrial fibrillation treatment devices is estimated to increase, owing to
the advancements in healthcare infrastructure and rise in expenditure in the emerging
economies such as China and India thereby, fueling market growth over the forecast period.
Some of the major companies operating in the atrial fibrillation market are Cardiofocus, Inc.,
Biosense Webster, Inc., Biotitic Se & Co. Kg, St. Jude Medical, Inc., Medtronic, Inc., Carima,
Inc., Boston Scientific Corporation, Ncontact, Inc., and Agricore, Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive